Salarius Pharmaceuticals, Inc.SLRX
Market cap
$1.53M
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -12.1 | -10 | -16.3 | -8.8 | -57.1 | -37.9 | -38.8 | -113.9 | -118.1 | -116 |
| Return on equity (%) |
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -12.1 | -10 | -16.3 | -8.8 | -57.1 | -37.9 | -38.8 | -113.9 | -118.1 | -116 |
| Return on equity (%) |